Updated just now · Live
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Its portfolio includes medicines and vaccines across oncology, internal medicine, hospital products, and rare disease.
Pfizer Inc. operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for PFE.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). PFE Stock Intelligence Report. [stoxpulse.com/stocks/pfe]
Disclaimer: The information on this page about Pfizer Inc. (PFE) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Pfizer Inc..
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
Pfizer Showcases Oncology Innovation and Next-Gene...
48m ago
Pfizer Inc. (PFE) is Attracting Investor Attention...
3h ago
StoxPulse AI results for PFE: Pulse Score 47/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$156.54B
P/E Ratio
18.2
EPS
$-0.29
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Its portfolio includes medicines and vaccines across oncology, internal medicine, hospital products, and rare disease.
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade)
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
Amazon One Medical Introduces Weight Management Program With Upfront GLP-1 Medication Costs
COVID shots, newer vaccines in limbo after US court halts Kennedy's advisory panel
Pfizer’s PADCEV Keytruda Priority Review Tests Bladder Cancer And Valuation Story
CICC Initiates Coverage of Pfizer Inc. (PFE) With an Outperform Rating